Evoke Pharma Announces Proposed Public Offering of Common Stock
Evoke Pharma Announces Proposed Public Offering of Common Stock Evoke Pharma Announces Proposed Public Offering of Common Stock SOLANA BEACH, Calif., Jan. 13, 2021 — Evoke Pharma, Inc. (Nasdaq: EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) disorders and diseases, today announced that it intends to offer and sell shares of its common stock in a “firm commitment” underwritten public offering. Evoke also expects to grant to the underwriter for the offering a 45-day option to purchase an additional 15% of the shares of common stock offered in the ...